Elekta wins lawsuit against Livian GmbH

Report this content

STOCKHOLM, March 8, 2021 – Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.

# # #

For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail: 
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail:
Time zone: CET: Central European Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.


Documents & Links